| Active substance |
Bromocriptine |
| Also known as |
Bromocriptine mesylate |
| Blood pressure |
Can cause hypotension |
| Category |
Pharma Grade |
| Chemical name |
2-Bromo-О±-ergocryptine |
| Dosage |
2.5 Mg |
| Dosage (medical) |
Typically 1.25 mg to 5 mg daily, depending on the condition being treated |
| Dosage (sports) |
Not typically used for athletic performance enhancement |
| Dosage Unit |
Tabs |
| ean13 |
1395847472172 |
| Effects |
Decreases prolactin levels, helps treat Parkinson's disease, and manages symptoms of hyperprolactinemia |
| FORM |
Oral |
| Formula |
C32H40BrN5O5 |
| Half-life |
Approximately 12 to 14 hours |
| Hepatotoxicity |
Low, but liver function monitoring is advised with long-term use |
| Lab Test |
Blood prolactin levels for effectiveness monitoring |
| Main action |
Dopamine agonist |
| Reference |
SPRM019 |
| Side effects |
Nausea, headache, dizziness, orthostatic hypotension, and vomiting |
| Storage conditions |
Store at room temperature, away from moisture and heat |
| Substance class |
Ergot alkaloid derivative |
| Tab Piece |
30 Tabs |
| Trade name |
Parlodel, among others |
| Use in sports |
Not commonly used in sports |
| Water Retention |
Minimal |
| Packing |
Blister |
